US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist
  • 7.905
  • +0.405+5.40%
Trading Jan 6 10:24 ET
1.09BMarket Cap-2.01P/E (TTM)

About Vir Biotechnology Company

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Company Profile

SymbolVIR
Company NameVir Biotechnology
Listing DateOct 11, 2019
Issue Price20.00
Founded2016
CEODr. Marianne De Backer, PhD
MarketNASDAQ
Employees587
Fiscal Year Ends12-31
Address1800 Owens Street,Suite 900
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-906-4324
Websitehttp://www.vir.bio

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Marianne De Backer, PhD
  • Chief Executive Officer and Director
  • 39.49M
  • Brent Sabatini
  • Senior Vice President and Chief Accounting Officer
  • --
  • Jason O'Byrne
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Ann M. Hanly, PhD
  • Executive Vice President and Chief Technology Officer
  • 3.11M
  • Jeffrey Calcagno, M.D.
  • Executive Vice President and Chief Business Officer
  • 4.54M
  • Sasha Damouni Ellis
  • Executive Vice President and Chief Corporate Affairs Officer
  • --
  • Jennifer Towne
  • Executive Vice President and Chief Scientific Officer
  • --
  • Dr. Vicki L. Sato, PhD
  • Chairman of the Board
  • --
  • Dr. George A. Scangos,PhD
  • Director
  • 338.20K
  • Jeffrey S. Hatfield
  • Independent Director
  • --
  • Dr. Elliott Sigal, M.D.,PhD
  • Independent Director
  • --
  • Robert J. More
  • Independent Director
  • --
  • Dr. Ramy Farid, PhD
  • Independent Director
  • --
  • Professor Dr. Norbert W. Bischofberger, PhD
  • Independent Director
  • --
  • Robert Taylor Nelsen
  • Independent Director
  • --
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • --
  • Janet Napolitano
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Coinbase
COIN
+7.23%
MicroStrategy
MSTR
+5.87%
Ecopetrol
EC
+2.90%
Alphabet-A
GOOGL
+2.69%
Alphabet-C
GOOG
+2.65%

Unlock the Full List